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ABSTRACT
Background: Key elements of treatment fidelity include treatment 
integrity (adherence to the treatment protocol) and treatment 
differentiation (the difference in treatment ingredients in the con-
trol and intervention groups). The Very Early Rehabilitation in 
SpEech (VERSE) trial established treatment fidelity at the macro 
level for key components of therapy.
Aims: To complete a detailed analysis of treatment integrity and 
differentiation at the utterance level of a therapeutic interaction.
Methods: This was an observational study of therapy videos col-
lected as part of the VERSE trial. Participants were people with 
aphasia in the very early phase of recovery post stroke (n = 44) 
and speech-language pathologists (n = 25). Therapist video 
recorded sessions in the intensive arms of the trial (VERSE- 
prescribed therapy and Usual Care Plus) and 53 therapy videos 
(12%) were randomly selected for analysis. Therapy sessions were 
transcribed, and key measures reflective of therapeutic inputs and 
client acts were coded to determine treatment integrity and differ-
entiation. A descriptive analysis and a Welch’s t-test for unequal 
variances were used to analyse the sessional data.
Results: Therapists in the VERSE (prescribed intervention) arm of 
the study, were highly adherent to the treatment protocol at the 
utterance level (M = 97%). Treatment differentiation between the 
intensive conditions in this sample was not achieved for cueing and 
error handling suggesting the treatment delivered between groups 
was similar.
Conclusions: Within this sample, treatment integrity to the pre-
scribed condition was maintained. Despite significant differences 
on a broad level, there was not significant differentiation in the 
therapy provided in the two arms of the trial at the utterance level. 
This result supports the null finding in effectiveness between the 
two intensive arms of the treatment as potential key measures were 
not different in dosage.
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Introduction
Treatment fidelity concept
Assessing and monitoring treatment fidelity is an important component of intervention 
studies; however, a single, widely agreed upon definition has not been developed (O’Shea 
et al., 2016). Most definitions, at a fundamental level, describe treatment fidelity as the 
degree to which the administration of a treatment corresponds to the specified protocol for 
the implementation of that treatment (Kaderavek & Justice, 2010). However, the definition of 
treatment fidelity has widened over the last twenty years to incorporate the concepts of 
treatment integrity, treatment differentiation, and treatment receipt (Borrelli et al., 2005). 
Treatment integrity or adherence refers to the extent to which the treatment is given as 
intended, while treatment differentiation determines if the therapy provided in the inter-
vention and control groups is sufficiently different in relation to the key or “active” ingre-
dients of the therapy provided (Moncher & Prinz, 1991). Treatment receipt is the processes 
implemented to monitor and improve the participant’s ability to comprehend and perform 
the behaviours targeted in the treatment (Bellg et al., 2004). This broader definition of 
treatment fidelity reflects the increased complexity of research and the demand for an 
evolving evidence base to guide clinical practice. To address this, there is a need to reliably 
report on elements of intervention that are regularly omitted in treatment studies (Walton 
et al., 2017). Strengthening processes for the planning, implementation, monitoring, and 
reporting on treatment fidelity in clinical trials help to ensure that interventions are delivered 
as per the study protocol, and the integrity of the treatment is preserved.
Addressing treatment fidelity can help to explain study findings, minimise errors in 
interpreting study outcomes, and inform future modifications to the intervention 
(Hoffmann et al., 2014). Monitoring and evaluating treatment fidelity within studies assists 
in the interpretation of study outcomes and may increase confidence in the relationship 
between intervention components and the outcomes of a trial (Rixon et al., 2016). While 
treatment fidelity is broached with caution by some, due to the real-world applicability of 
strict treatment protocol procedures (Karas & Plankis, 2016), implementation of thorough 
treatment fidelity procedures has the aim of building a robust body of evidence for interven-
tions. If the scientific basis for clinical practice is built on studies that have not effectively 
investigated treatment fidelity, then systematic reviews, meta-analyses, and clinical practice 
guidelines may be skewed (Wheeler et al., 2006). Additionally, studies with high fidelity 
monitoring and reporting have increased external and internal validity and are more likely 
to be replicable (Borrelli, 2011). High levels of fidelity reporting also allow comparisons to be 
made between treatments (Hildebrand et al., 2012; Moncher & Prinz, 1991; Resnick et al., 2005; 
Schlosser, 2002). While the importance of planning for and assessing treatment fidelity has 
been highlighted, treatment fidelity processes are not always incorporated within interven-
tion studies (Bellg et al., 2004). For example, Borrelli et al. (2005) evaluated 342 behaviour 
change articles between 1990 and 2000 and found that overall, 54% of the studies did not 
report intervention fidelity.
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Treatment fidelity in complex interventions
Complex interventions are “health service interventions that are not drugs or surgical 
procedures but have many potential active ingredients” (Oakley et al., 2006, p. 413). 
Behavioural interventions, such as those used in speech-language pathology (SLP), are 
complex, and treatments implemented have been described as “black boxes” referring 
to the fact that they may contain many potential active ingredients that shape patient 
outcomes (DeJong et al., 2005; Walker et al., 2017). Additionally, due to the inherent 
complexity of behavioural interventions, there may be more variation when different 
sites and providers are involved in intervention studies (O’Shea et al., 2016) resulting 
in potential issues with training of providers and delivery of treatment such as 
contamination between conditions or therapist drift. Therapist drift refers to 
a decrease in desired therapy skills or adherence to protocol over time. Treatment 
fidelity is especially relevant to behavioural change interventions due to this complex-
ity (O’Shea et al., 2016). Investigating therapy fidelity measures encourages researchers 
to deconstruct and make explicit what is inside the “black box” of rehabilitation 
intervention (Hand et al., 2018). Currently, the incorporation of treatment fidelity 
processes is more established in the field of psychotherapy research compared to 
medical rehabilitation research (Hildebrand et al., 2012). Treatment fidelity has been 
made of such value in the psychotherapy literature that only research that includes 
substantial attention to this is considered as reliable evidence for the efficacy of 
a treatment. In 2008, it was recommended that psychotherapy sessions should be 
videotaped and a random selection of 20% should be rated for treatment adherence 
and therapy competence (Öst, 2008). Although not as established as the psychother-
apy literature, increasing attention is being given to treatment fidelity in rehabilitation 
interventions in stroke. Similar to psychotherapy, stroke interventions are often beha-
vioural in nature, delivered via a therapist and are likely to have a range of potentially 
active ingredients.
Treatment fidelity processes should be incorporated when designing a study, when 
implementing the study and also when reporting the findings (Borrelli, 2011; Brogan et al., 
2019). The importance of assessing treatment fidelity has been emphasized in recent 
guidelines and recommendations for evaluating complex interventions (Rixon et al., 
2016); however, guidelines are needed to define treatment fidelity concepts and to 
provide standardisation regarding key aspects of treatment fidelity (Gearing et al., 
2011). The Treatment Fidelity Workgroup of the National Institutes of Health Behaviour 
Change Consortium (Bellg et al., 2004) reviewed treatment fidelity practices used within 
the identified literature and developed recommendations to embed treatment fidelity 
practices within intervention studies. Recommendations for addressing treatment fidelity 
in behaviour change studies were outlined across five main areas: study design, training 
providers, delivery of treatment, receipt of treatment, and enactment of treatment skills 
(Bellg et al., 2004; Borrelli, 2011). Additionally, Gearing et al. (2011) provided a treatment 
fidelity guide, identifying four core components from the treatment fidelity literature with 
less of an emphasis on treatment enactment, the fifth category in the Bellg et al. (2004) 
framework. Gearing et al.’s (2011) guide provides a chronological outline incorporating 
study design, training, monitoring intervention delivery, and monitoring intervention 
receipt. The guide encourages researchers to address some broader areas of study design, 
APHASIOLOGY 3
such as the overall framework. The elements included in both the Bellg et al. (2004) 
framework and Gearing et al.’s (2011) guide are very similar, with Bellg et al. (2004) being 
the most widely applied in research (O’Shea et al., 2016).
Documenting fidelity involves investigating therapy effectiveness, including key ingre-
dients and the dosage delivered of these (Kaderavek & Justice, 2010). Specification of 
therapy ingredients is central to all areas of Bellg et al.’s (2004) framework, and dosage is 
important for determining whether the therapist adhered to the protocol and whether 
the intervention groups received different amounts or types of intervention. Warren et al. 
(2007) proposed a comprehensive model for defining dosage and calculating cumulative 
intervention intensity. The model included the term “dose form” which is defined as the 
task or activity within which the teaching episodes are delivered and it may contain the 
important active ingredients of the intervention. Potential active ingredients may involve 
therapeutic inputs (therapist behaviours) and client acts (client behaviours) (Baker, 2012). 
When designing a treatment, it is important that researchers give significant considera-
tion to the theoretical underpinnings of the treatment so that the potential active 
ingredients and the required dosage are identified and then adequately monitored and 
evaluated (Borrelli, 2011). As such, the planning of treatments may be as complex and 
detailed as the treatment itself. If researchers fail to recognise potential factors that may 
facilitate change in the participants at the design stage, the appropriate data may not be 
collected, evaluated, and reported (Walker et al., 2017). Specification of ingredients in the 
study design allows therapists to be trained in delivering those ingredients and decisions 
on the monitoring of implementation of the ingredients in therapy can be made. How to 
monitor treatment delivery presents a challenge as there are few validated tools to use for 
the investigation of treatment fidelity in behavioural interventions (Borrelli et al., 2005).
Treatment integrity has been incorporated as a feature of behavioural intervention 
studies (Damschroder et al., 2016; Hildebrand et al., 2012; Seng & Lovejoy, 2013; Thomas 
et al., 2016) with stricter protocol adherence linked to improved study outcomes 
(O’Donell, 2008; Perepletchikova & Kazdin, 2005). Treatment integrity is commonly inves-
tigated by measuring the therapist’s adherence to the treatment protocol through the use 
of structured observations. These observations are carried out in person or via recording 
and typically involve the completion of checklists (Borrelli, 2011). As a gold standard, the 
checklist should be developed using a priori coding categories, which reflect the potential 
factors that are identified during the development of the study design (Kaderavek & 
Justice, 2010). The checklist may also be used for the collection and analysis of data for 
treatment differentiation (Hildebrand et al., 2012). One criticism is that direct observation 
may be more prone to bias because the treatment variable is predefined and an observer 
might report what the therapist is supposed to do rather than what actually happened 
(Schlosser, 2002).
Treatment fidelity information should be included in detailed treatment descriptions 
and in the reporting of trial results (Moher, 2018) although this is infrequently done 
(Conlon et al., 2020). Current papers may limit their investigation and reporting of 
treatment fidelity to study design or protocol adherence only (O’Shea et al., 2016; Spell 
et al., 2020) and not addressing the five areas of treatment fidelity (Bellg et al., 2004). 
Several guidelines now exist to help authors include important intervention details 
including information on treatment fidelity (Moher, 2018). For example, checklists such 
as the Template for Intervention Description and Replication (TIDieR) (Hoffmann et al., 
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2014) were established to encourage more complete reporting of treatments and to 
address the “remarkably poor” (p. 1) intervention description quality. While the TIDieR 
checklist includes general items related to the therapy such as task selection, therapy 
location, and dosage, it also includes treatment fidelity-specific items related to planned 
(item 11) and actual (item 12) treatment fidelity (Hoffmann et al., 2014). These items go 
beyond simple receipt of the intervention and refer to how well the intervention was 
received or delivered (Hoffmann et al., 2014). With a recent emphasis on treatment 
fidelity, publications addressing this area specifically within clinical trials have been 
published (Behn et al., 2018; Carragher et al., 2019; Conlon et al., 2020; McLennon et al., 
2016; Resnick et al., 2011; Spell et al., 2020) providing exemplars for the reporting of 
treatment fidelity analyses. This has included the specific quantitative reporting of pro-
tocol adherence.
Treatment fidelity in aphasia
The adequacy of SLP randomised controlled trials (RCT) intervention descriptions, across 
all SLP practice areas, not just within aphasia trials, was assessed against the TIDieR 
checklist (Hoffmann et al., 2014) with 46% of studies included reporting on treatment 
fidelity (Ludemann et al., 2017). Hinckley and Douglas (2013) investigated treatment 
fidelity reporting within the aphasia literature and found 21/149 (14%) of studies reported 
treatment fidelity between 2002 and 2011. More recently Brogan et al. (2019) reported 9/ 
42 (21%) aphasia RCTs published between 2012 and 2017 explicitly reported on treatment 
fidelity processes. The least addressed aspect of treatment fidelity was ensuring partici-
pants used the skills gained in treatment in appropriate life settings, with only two (2%) 
articles including this. Poor monitoring of treatment fidelity was also reported specifically 
in verb treatments (Hickin et al., 2020).
Increasingly published research protocols are using the current gold standard techni-
que of video recording therapy sessions and assessing these according to a priori criteria. 
These studies include the Aphasia Action Success Knowledge (ASK) trial (Worrall et al., 
2016), Predicting and Promoting Sub-acute Aphasia Recovery (PAPAR) (Copland, 2017), 
SUpporting well-being through PEeR-Befriending (SUPERB) trial (Behn et al., 2018) and the 
COMPARE trial (M. Rose et al., 2019). Other studies such as BIG CACTUS (Palmer et al., 
2015) have advantages with computerised therapy in obtaining fidelity data via logs 
without relying on therapist reports or monitoring therapist participant interactions. An 
additional level of therapy fidelity is the monitoring of recorded sessions and providing 
feedback to the therapist to change aspects of their therapy delivery and increase 
protocol adherence, while treatment is still being delivered. ASK (Carragher et al., 2019), 
COMPARE (M. L. Rose et al., 2019) and VERSE (Godecke et al., 2020b) have incorporated 
this element.
Very Early Rehabilitation in SpEech (VERSE) trial
This study involved the analysis of a subset of data from the VERSE trial. The findings of 
the VERSE trial indicated that communication outcomes were equivalent for usual care 
therapy and early intensive therapy at 12 and 26 weeks post stroke (Godecke et al., 
2020b). Usual care was documented to be therapy provided an average of two to three 
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times per week for approximately 40 min (9.5 hours in total in the first 50 days after stroke) 
and this resulted in improved communicative ability after stroke as measured by the 
outcome on the Western Aphasia Battery Revised – Aphasia Quotient (WABR- 
AQ) (Kertesz, 2006). Intensive intervention (22 hours in total in the first 42 days after 
stroke) provided within the Usual Care-Plus and the prescribed VERSE intervention arms 
of the trial did not cause harm but did not provide a statistically significant benefit to 
participants over and above the usual care regimen (Godecke et al., 2020b).
The interventions in the trial were as follows:
(i) Usual Care: Participants randomised to this group received care that is typical for 
aphasia management in the Australian and New Zealand healthcare settings and 
was at the discretion of the treating SP. It also included management of other 
speech pathology impairments such as dysphagia, dysarthria, and/or apraxia of 
speech. Only direct aphasia therapy time was included in the analysis for the 
primary VERSE result. Usual care therapy was recorded over a period of 20 working 
days.
(ii) Usual Care-Plus: Participants received treatment that is typical of direct aphasia 
therapy, at the discretion of the treating SP as per the Usual Care group, but with 
a defined intensity therapy regimen of daily sessions for 45–60 minutes duration 
over 20 sessions. Direct aphasia therapy included 1:1 impairment-based therapy, 
impairment-based computer training, social training, group impairment-based 
therapy, group social training, and Augmentative and Alternative 
Communication (AAC) training.
(iii) VERSE intervention: The intensity of this arm of therapy matched that of the Usual 
Care-Plus arm but the intervention was impairment-based, prescribed, and stan-
dardised according to a specific VERSE intervention protocol. As per treatment 
fidelity recommendations, when planning the prescribed intervention, the theore-
tical underpinnings of the treatment were highlighted, allowing these to be 
monitored and evaluated. This intervention was founded on principles to promote 
neurorecovery: i) massed practice, ii) error-free learning, iii) task complexity, iv) 
salience, and v) maximising communicative success.
The current study
Treatment fidelity processes were developed and implemented within the VERSE trial. 
Treatment integrity and differentiation were established in the main study, at a broad 
level, between treatment conditions. However, with a trial of this size, including 8915 
completed therapy sessions, fine-grained analysis of all therapy sessions was not feasible. 
The researchers placed importance on investigating a proportion of the sample with 
greater detail. In the present treatment fidelity study, we investigated the dose form, as 
per Warren et al. (2007), given in the two arms of the trial to establish treatment integrity 
and differentiation. In the VERSE trial, the intensity was prescribed for the two intervention 
arms at twenty sessions; however, the dose form given and received within a session was 
not prescribed. This therefore provides an opportunity to investigate treatment integrity 
and differentiation. According to Baker (2012) dose form involves both the therapeutic 
inputs and client acts of a task. Therapeutic inputs refer to behaviours by the therapist 
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within the task that are thought to be therapeutic in nature. Similarly, client acts are 
behaviours that may contribute to the therapeutic effect. Integrity and differentiation 
results have been framed according to these elements within the current study. As the 
interventions provided within the VERSE RCT were behavioural and interactional in 
nature, treatment integrity and differentiation were investigated at the utterance level 
in this study, with the following aims:
(i) To determine treatment integrity (protocol adherence) for the task (dose form) and 
therapeutic inputs (cueing and error handling) to the VERSE intervention protocol.
(ii) To determine the level of treatment differentiation (dose form given within ses-
sions) for the task, therapeutic inputs (cueing) and client acts (verbal output, errors), 




This study used therapy videos collected as part of the VERSE RCT. Participants were 
recruited to the VERSE trial if they had aphasia secondary to an acute intracerebral 
haemorrhage or ischaemic stroke; were 18 years of age or over; had corrected hearing 
and vision; were medically stable at or before 14 days post stroke; and could participate in 
aphasia therapy in English without the need for an interpreter. Exclusion criteria included 
pre-existing aphasia prior to admission into the hospital; a history of progressive neuro-
logical disease, neurosurgery, major depression, subdural or subarachnoid haemorrhage; 
and an inability to maintain alertness for 30 consecutive minutes at 14 days post stroke. 
VERSE recruited 246 participants, 81 in Usual Care, 82 in Usual Care-Plus, and 83 in VERSE, 
across Australia and New Zealand. Participants were assessed at a baseline of 12 and 
26 weeks post stroke on a range of impairment, psychosocial, and economic measures. 
The primary outcome measure for VERSE was the WABR-AQ (Kertesz, 2006) at 12 weeks 
post stroke.
The participants for the current study represent a sample subset from the broader 
VERSE RCT. As part of the treatment fidelity processes embedded within the VERSE RCT, 
VERSE and Usual Care-Plus therapists were required to video record one therapy session 
per week, resulting in four or five recordings per participant (please see below for more 
details on the VERSE RCT treatment fidelity processes). For practical reasons, it was 
suggested to therapists to video record session numbers five, 10, 15, and 20, however, 
therapy videos for any session were accepted.
An independent research assistant used a computer-generated block randomisation to 
select therapy videos for this study. This process was stratified for aphasia severity (mild, 
moderate, and severe aphasia as determined by the WABR-AQ at baseline). For the videos 
to be included within the study, participants were required to have outcome scores at 
12 weeks (primary outcome) and 26 weeks on the WABR-AQ and have completed the full 
treatment protocol. Additionally, videos needed to be at least 40 min in length, not 
contain the present author as the therapist and be playable on Windows Media Player. 
The sample comprised 53 videos, which was 12% of the 434 therapy videos received 
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through the trial. See Table 1 for participant demographics included in this study. Of the 
53 randomly selected videos, seven participants had two videos in the sample (total 14 
videos), one participant had three videos in the sample (total of 3 videos), and the 
remaining 36 participants had one video each (total 36 videos). This resulted in the 
inclusion of 44 different participants. Twenty-seven SLPs are also included in the videos. 
SLPs were hired specifically for the trial and were required to be eligible for membership 
to Speech Pathology Australia. All treating SLPs underwent training (3 hours) and received 
procedural and training manuals relevant to the arm of therapy they were providing. 
Clinical support was provided by trial clinical staff as required throughout the trial. VERSE 
therapists were then given additional training (2 hours) to administer the prescribed 
therapy (Godecke et al., 2020a).
Treatment fidelity within VERSE
All therapists within the trial completed standardised therapist training, including the 
provision of manual and logged session data. Additionally, therapists in the intensive 
arms of the trial (Usual Care-Plus and VERSE) were required to video record a set number 
of sessions across the intervention period. The Therapy Fidelity Monitor (TFM) checked 
that therapy for participants in the intensive arms of the study was commenced on or 
before day 15 post stroke and that it did not continue beyond 50 days post stroke. The 
duration and frequency of each session within the intensive arms of the trial were also 
monitored to ensure it was 45–60 minutes of direct aphasia therapy, for a maximum of 
five sessions per week for 20 sessions and completed within 4 weeks. For the prescribed 
VERSE intervention arm, key therapy ingredients were identified within the study design. 
This guided therapist training and the monitoring of therapy delivery. VERSE intervention 
therapists received a specific therapy manual and received one on one support in order to 










VERSE High Intensity 
cohort 
(n = 164)b
Age, Mean (SD) 72.0 (14.8) 75.0 
(14.2)
68.0 (14.7) 75 (18)
Female 19 (43%) 12 (48%) 7 (37%) 80 (49%)
Oxford Stroke Classification c
Haemorrhagic 3 (7%) 2 (8%) 1 (5%) 13 (8%)
PACs 34 (77%) 18 (72%) 16 (84%) 110 (67%)
PoCs 1 (2%) 0 (0%) 1 (5%) 6 (4%)
TACs 6 (14%) 5 (20%) 1 (5%) 35 (21%)
Baseline WABR-AQ Severity
Mild 15 (34%) 8 (32%) 7 (37%) 47 (29%)
Moderate 13 (30%) 7 (28%) 6 (32%) 49 (30%)
Severe 16 (36%) 10 (40%) 6 (32%) 68 (41%)
Modified Rankin Scale Score (mRS)
Low disability (mRS 0–2) 6 (14%) 5 (20%) 1 (5%) 16 (10%)
High disability (mRS 3–5) 38 (86%) 20 (80%) 18 (95%) 148 (90%)
National Institutes of Health Scale Score, Mean 
(SD)
9.1 (7.1) 9.4 (7.5) 8.7 (6.5) 9 (6)
Note. a Within this substudy, 53 videos were selected through randomisation with 8 participants having more than one 
video in the sample. Therefore, 44 different participants are included in this demographics table. b This column 
represents the VERSE high intensity cohort as a whole from the primary study for comparison purposes. c PACs = Partial 
Anterior Circulation syndrome; PoCs = Posterior Circulation syndrome; TACs = Total Anterior Circulation syndrome.
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implement the therapy as prescribed. The TFM monitored that prescribed targets as per 
the protocol were met, including delivering conversation-based therapy at the target goal 
level. They also monitored major VERSE protocol elements broadly, such as the timing and 
type of cueing used by the therapist and scaffolding of correct productions. This resulted 
in an overall rating of the session as adherent or non-adherent to VERSE protocol. The TFM 
and Therapy Fidelity Co-ordinator was responsible for feeding back to the therapists 




In this study, each video was transcribed verbatim and utterances segmented following 
the guidelines provided within the Systematic Analysis of Language Transcripts (SALT) 
(Miller, 2008) software and as per SALT guidelines (available at http://saltsoftware.com/ 
resources/tranaids).
Coding
During transcription, codes developed specifically for this research were applied at the 
word and utterance level of the transcript for both therapeutic inputs and client acts. 
Variables of interest were selected as possible key points of difference between treat-
ments based on the theoretical underpinnings of the VERSE therapy protocol. For exam-
ple, the quantity and accuracy of the participant’s production was a key consideration as 
the VERSE protocol incorporated the principle of maximising communicative success 
through the use of salient communication-based tasks and error minimisation strategies 
(error-free production). Rationales for the coding systems are explained in the relevant 
sections below.
Treatment integrity – protocol adherence.
Task (dose form). Integrity or adherence to the VERSE prescribed treatment required 
therapists to implement conversation-based tasks aimed at eliciting an accurate phrase 
structure at the appropriate level for the participant. This appropriate level is called a “goal 
level”. The rationale for verbal conversation tasks in the VERSE protocol was i) that 
improvement in therapy is experience dependent; ii) a lack of experience of practicing 
a task may result in learned non-use; and iii) conversation is salient to the person with 
aphasia, a key neuroplasticity principle (Pulvermuller & Berthier, 2008).
A summary of the goal levels of the prescribed treatment and subsequent coding is 
presented in Table 2. For example, if goal two was chosen as the starting point for the 
participant based on baseline data, the therapist was trained to facilitate the production 
of verbal output at a minimum of single word level. If the participant independently 
achieved 80% success during the session, they progressed to the next goal. Utterances 
from the participant were coded as either at, above, or below the targeted goal level. The 
target goal level of each session was coded, to account for incremental improvement 
throughout the treatment period. These codes were then counted to allow a calculation 
of the percentage of utterances that were at or above the target goal level. The mean 
length of utterance (MLU) during the therapy session, as per the SALT analysis, was also 
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used to determine protocol adherence to see whether it matched the predetermined goal 
level of the session. This measure is average and broader than the utterance by utterance 
analysis. The MLU analysis provides an overall measure of the mean length of utterance 
for the entire session, whereas the utterance analysis was a point-to-point count.
Therapist inputs. The video transcriptions for the VERSE intervention group were coded 
according to therapeutic inputs that adhered to VERSE treatment elements and those that 
did not. All therapist utterances that did not meet the criteria for non-adherence were 
deemed adherent to the therapy protocol. After coding and counting, a percentage of 
therapeutic inputs that adhered to VERSE treatment elements for each session was 
established.
There was a specific focus on how the therapist responded to participant errors with 
cueing. Cues were used by the therapist to promote accuracy and participation by 
assisting in word retrieval and/or accurate speech production. In the VERSE protocol, 
therapists were required to establish the type of cue that is most effective for the 
participant. Therapists were encouraged not to repeat cues that were ineffective. An 
utterance would be marked as a protocol deviation if the therapist used the same cue 
type more than once for the same stimulus and it was unsuccessful.
VERSE therapy incorporated the principle of error-free practice. Therefore, therapists 
were encouraged to limit the participant to no more than three errors on a stimulus. The 
utterance was marked as a protocol deviation if the participant made more than three 
Table 2. Summary of coding for task adherence.
Goal 




1a Receptive: Identification of 
verb pictures from spoken 
words
Any verbal output is appropriate. Cannot mark as 
being below goal level. Can mark as above goal level 
for any verbal output that is not an error.
0
1b Receptive: Identification of 
noun pictures from spoken 
words
0
1c Receptive: Identification of 
adjectives pictures from 
spoken words
0
2 Verbal production of single 
words
If not responding verbally then mark as below the 
appropriate goal level. Can mark as above goal level if 
above this level.
1
3 Verbal production of two 
element phrases or clauses
If responding at single-word level including yes/no 
responses then mark as below the appropriate goal 
level. Can mark as above goal level if above this level.
2
4 Verbal production of three 
element phrases or clauses
If responding below three element clause then mark 
as below the appropriate goal level. Can mark as 
above goal level if above this level.
3
5 Verbal production of complex 
clauses and/ or phrases
If responding with three element clauses or less then 
mark as below the appropriate goal level. Can mark as 
above goal level if above this level.
4
6 Verbal production of complex 
phrases (verb and noun) and 
clauses
If responding below a complex phrase mark as below 
the appropriate goal level. Can mark as above goal 
level if above this level.
5
7 Verbal conversation about 
familiar topics
Cannot mark as above goal level. At conversation level 
utterances must be above a complex phrase otherwise 
they will be marked as below the appropriate goal 
level.
>5
8 Verbal conversation about 
unfamiliar topics
>5
Note. MLU = Mean Length of Utterance
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errors for one stimulus and a model was not given after the third error. Every subsequent 
cue and utterance for the same stimulus by the therapist, which allowed the participant to 
continue making errors, was marked as a protocol deviation.
Treatment differentiation.
Task (dose form). Tasks were coded with a description of the activity (e.g., picture 
naming), the target language process (i.e., expressive verbal, expressive written, receptive 
auditory, or receptive written) and the target phrase level (i.e., single-word level, sentence, 
or conversation) to enable dose form differentiation. For conversation to be included as 
a task, it needed to be the target of therapy, including therapeutic inputs such as cueing 
and feedback. Filler conversation and rapport building at the beginning or end of the 
session was not included.
Therapist inputs. Measures related to therapeutic inputs were coded in order to assess 
whether the treatment provided in the two intervention groups was significantly differ-
ent. The therapeutic inputs of interest were related to cueing. The specific cues focused 
on in this study were phonemic, semantic, orthographic, visual, forced alternative, sen-
tence completion, articulatory placement, and direct model cues. A cue was coded if 
a relevant cue was used by the therapist. If the cue was successful in eliciting an 
appropriate response from the participant, it was marked as a cue used with success. 
Turkstra et al. (2016) suggested investigating ingredients, such as handling of errors and 
their effect on target attainment, more generally across a therapy session rather than 
looking at the impact of these ingredients separately for each activity. This approach was 
used within this study and so the treatment sessions were examined as a whole to analyse 
therapist tailoring of cues and whether the use of the cues resulted in successful partici-
pant/client performance. Codes were then counted to provide totals and percentages for 
each session. In addition, calculations were performed by the SALT software (total 
therapist utterances, total therapist words, and utterances per minute) and used in the 
analysis.
Client acts. Measures related to client acts were coded to assess whether the partici-
pants’ response to the treatment provided in the two intervention groups was signifi-
cantly different. Aphasia treatment approaches are often described as “error full” or 
“errorless” referring to whether patients are encouraged to attempt target attainment 
irrespective of the error quantity or whether errors are minimized to avoid strengthen-
ing of associated negative neural networks. Reducing errors in therapy relates to 
Hebbian theory surrounding coactivation of neurons and that a mistake occurring 
while producing a word may wire together these two behaviours (Hebb, 1949; Varley, 
2011). It aims to avoid therapy being the practice of errors (Varley, 2011). Errorless 
learning may reflect implicit learning techniques that may be suited to the motor 
learning required in speech production (Page, Wilson, Norris 2006). As such, the 
codes of focus reflected the quantity and accuracy of utterances. Each utterance was 
marked as error free if it contained no errors. An error made by the participant was 
marked at the word level. It was further coded for error types including filled and 
unfilled pauses, phonology, perseveration, circumlocution, semantic, grammatical, 
repetition fluency, receptive, and unintelligible errors. Errors that were self-corrected 
prior to therapist intervention were coded as self-corrections. The codes were then 
counted to provide totals and percentages for each session. In addition, calculations 
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were performed by the SALT software and used in the differentiation analysis. These 
were mean length of utterance (MLU) in both words and morphemes, total verbal 
utterances, total words, words per minute (WPM), utterances per minute (UPM) and 
mean turn length in words.
Additionally, calculations were performed manually according to the formulas in Table 
3 and used in the analysis.
Statistical analysis
Descriptive statistical analyses for treatment integrity and differentiation measures 
were completed. As the session length of the videos was not equal, the time of the 
session was used to standardise the data [measure/session time (mins)] for the 
following measures: total error-free utterances, total errors, spontaneous verbal out-
put, total self-corrections, total verbal utterances, total words, utterance-level errors, 
word-level errors, total cues used with success, total therapist utterances, and total 
therapist words. A Welch’s t-test for unequal variances was performed using the 
above measures to determine whether Usual Care-Plus and VERSE conditions were 
significantly different. This test was used as it is robust to unequal sample sizes. 
A Bonferroni correction was applied for multiple comparisons and significance was 
set at p< 0.001.
Reliability
Six videos (one from each aphasia severity in Usual Care-Plus and VERSE groups) were re- 
coded for inter- and intra-rater reliability. This comprised 11% of the total sample in this 
study. Reliability was established using the intra-class correlation coefficient (ICC) in SPSS 
(IBM Corp, 2015) with a consistency 2-way mixed-effects model. The ICC was established on 
the four key measures of interest in the study – error-free utterances, total errors made, (iii) 
total self-corrections, and (iii) the total number of cues used with success by the therapist. 
Koo and Li (2016) guidelines for reporting the ICC have been adhered to in the tables below.




The number of verbal utterances that were generated spontaneously, e.g., not 
a repetition of a model or a gesture (verbal utterances) – (repetitions + gestures)
Utterance Level Errors Total of the number of errors that occur at the utterance level based on codes in the 
transcript.
Word Level Errors Total of the number of errors that occurred at the word level based on codes in the 
transcript.
% errors self-corrected Self-corrections/Total errors x 100
Average no. of errors per 
utterance
Verbal errors/Verbal utterances
Average no. of utterances 
per error
Verbal utterances/Verbal errors
% total words with errors Errors/Total words x 100
Verbal utterances Total utterances – Gestures
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Inter-rater reliability
As per Supplement 1, three of the measures had ICCs in excess of 0.90, and, therefore, inter- 
rater reliability can be said to be excellent. The self-corrections measure was lower; how-
ever, ICCs in the range of 0.75–0.90 remain in the good reliability range (Koo & Li, 2016).
Intra-rater reliability




Protocol adherence-task (dose form)
The majority of participant utterances within tasks were at the target goal level. The goal 
level refers to the target verbal output level during the session and ranges from a target 
MLU of 0 to >5. An average of 67% of utterances was at the target goal level within 
a session. On average, 8% of utterances by the participant in a session were above the 
target goal level of the session. Table 4 provides descriptive statistics for the therapists’ 
adherence to the target goal level for the VERSE condition measured at the utterance 
level.
A higher level of dosage adherence was seen using the MLU analysis compared to the 
utterance by utterance dosage adherence measures above. The MLU analysis provides an 
overall measure of the mean length of utterance for the entire session, whereas the 
dosage adherence measures above were point-to-point count. Of the 28 VERSE sessions 
analysed, 24 (86%) had an MLU at or above the target goal level for the session. This 
represents a high level of protocol adherence.
Protocol adherence – therapeutic inputs
Therapists produced, on average, 671 utterances (SD = 278.1) per session in the VERSE 
condition. There were on average 15 protocol deviant utterances per session (inclusive of 
the same cue and error deviations) with 97.6% of utterances by the therapist being 
adherent to the VERSE intervention protocol. Where deviations were observed, allowing 
the participant to make more than three errors was observed most frequently, occurring 




Descriptive statistics for the tasks completed in this study are presented in Table 6. The 
prescribed protocol was designed to focus on verbal language output and encourage 




Descriptive statistics for therapeutic inputs are presented in Table 7. To maintain context, 
the means and standard deviations are presented in raw format prior to time adjustment 
[measure/session time (mins)]. After statistical analysis, the groups were not found to be 
significantly different with p > 0.001.
Table 4. Measures of central tendency for protocol adherence to task.
Measure VERSE (n = 28 videos)
Error free and at appropriate goal level
Mean (SD) 197.2 (124.6)
Median 172.5
Interquartile range (IQR) 161
% total utterances 38.6%
Error free not at appropriate goal levela
Mean (SD) 128.4 (87.6)
Median 122.0
IQR 114.0
% total utterances 25.1%
Contains an error and at the appropriate goal level
Mean (SD) 185.7 (123.9)
Median 149.0
IQR 129
% total utterances 36.4%
Contains an error and not at appropriate goal level a
Mean (SD) 64.0 (56.3)
Median 48.0
IQR 55.0
% total utterances 12.5%
Above goal level
Mean (SD) 36.2 (31.7)
Median 31.0
IQR 63.0
% total utterances 7.0%
% utterances above goal level
Mean (SD) 8.2 (8.5)
Median 6.1
IQR 12.1
Not at target goal level
Mean (SD) 192.4 (124.3)
Median 159.0
IQR 175
% utterances at correct goal level
Mean (SD) 67.2 (24.4)
Median 66.3
IQR 38.2
Note. a Not at appropriate goal level includes utterances that were below the target goal 
level only.
Table 5. Means and standard deviations for session protocol 
adherence – therapeutic inputs.
Measure VERSE (n = 28 videos)
Total deviant utterances Mean (SD) 14.9 (17.3)
Protocol deviant utterances (same cue) 4.3 (7.5)
Protocol deviant utterances – x 3 errors 10.0 (12.5)
Protocol adherent behaviours 656.3 (273.6)
% Utterances that adhere to protocol 97.6 (3.2)
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Client acts
Descriptive statistics for client acts are presented in Table 8. To maintain context, the 
means and standard deviations are presented in raw format prior to time adjustment 
(measure/session time (mins)). After statistical analysis, the groups, Usual Care-Plus, and 
VERSE were not found to be significantly different with p > 0.001.
Discussion
This study sought to establish treatment integrity and treatment differentiation for the VERSE 
trial in a detailed transcript analysis of the therapy sessions. VERSE was the largest RCT in early 
aphasia recovery completed to date. The analysis of the wealth of treatment fidelity data 
collected in the trial is imperative to further analyse and interpret the trial outcomes.








Total number of tasks 152 56 96
Total number of verbal tasks (%) 114 (75%) 48 (86%) 66 (69%)
Total verbal tasks at single word level (%) 53 (46%) 13 (27%) 40 (61%)
Total verbal tasks at conversation level (%) 16 (14%) 12 (25%) 4 (6%)
Table 7. Descriptive and t-test statistic for treatment differentiation – therapeutic inputs.
Measure
VERSE 
(n = 28 videos)
Usual Care-Plus 
(n = 25 videos) p value
Therapist total utterances Mean (SD) 671.1 (278.1) 679.6 (226.0) .577
Cues used with success by therapist 29.6 (27.4) 38.5 (48.5) .424
Total cues used by therapist 77.3 (72.3) 86.6 (74.8) .631
% Cues that were successful 41.5 (20.0) 38.2 (26.9) .625
Therapist total words 2687 (948.5) 2848.6 (857.9) .518
Therapist utterances per minute 12.5 (4.9) 14.5 (7.6) .283
Table 8. Descriptive and t-test statistic for treatment differentiation – client acts.
Measure
VERSE 
(n = 28 videos)
Usual Care-Plus 
(n = 25 videos) p value
Total Verbal Utterances Mean (SD)* 474.2 (213.7) 483.4 (225.1) .651
Error free utterances* 311.8 (135.5) 302.5 (139.6) .979
Errors* 242.9 (134.6) 211.9 (135.7) .521
Spontaneous verbal* 250.0 (161.0) 257.3 (144.5) .661
Self-Corrections* 49.2 (64.0) 22.0 (22.0) .040
% errors self-corrected 17.6 (18.1) 12.6 (14.4) .276
Total words* 1847.4 (1460.7) 1511.6 (1128.2) .402
MLU (words) a 3.5 (2.1) 2.9 (1.4) .230
MLU (morphemes) a 3.9 (2.3) 3.2 (1.5) .212
Average errors per utterance (errors/utt.) 0.5 (0.3) 0.4 (0.2) .115
Average utterances per error (utt/errors) 2.4 (1.3) 2.8 (1.3) .349
Utterance Level Errors 24.3 (27.2) 23.4 (34.0) .854
Word Level Errors* 232.4 (162.0) 227.4 (162.3) .997
% total words with errors 33.5 (52.1) 22.5 (25.5) .326
Utterances per minute 9.7 (3.1) 9.8 (3.6) .892
Words per minute 35.7 (27.7) 29.5 (19.8) .355
Note. a Mean Length of Utterance, * Variables that were adjusted for time as the session length of the videos was not 
equal (measure/session time (mins).
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Treatment integrity
Results in this sub-study suggest therapists, providing therapy in the intensive VERSE 
arm of the trial, were adherent to the prescribed treatment protocol. This was estab-
lished by measuring the therapists’ adherence to the target task level. On average, the 
target level of verbal output was achieved in 67% of participant utterances in this 
sample of sessions from the VERSE arm, as per protocol. When looking at a broader 
session view, the target phrase structure achieved 86% of the time when measured by 
the mean length of utterance. Protocol adherence for the therapeutic inputs was high 
at 98% with minimal deviations. Therefore, the key VERSE elements of minimising 
errors and encouraging verbal output were delivered by the therapist, and it is possible 
to establish treatment integrity to the dose form within this sample. There is no 
accepted minimum level of integrity that is required in a complex, behavioural RCT; 
however, the TF literature suggests protocol adherence of 80% or greater to be 
considered as a high fidelity level (Borrelli, 2011; Borrelli et al., 2005; Perepletchikova 
& Kazdin, 2005). Regardless, it is important to report what was intended compared to 
what was received (Brogan et al., 2019). Additionally, adherence to the intensity of the 
protocol is more commonly reported than adherence to key therapeutic elements 
within sessions (Bakheit et al., 2007; Resnick et al., 2011). However, this study has 
shown that it is possible for aphasia studies to monitor adherence to key therapeutic 
elements within therapy sessions and report quantitative values for this. Our findings 
are consistent with other levels of reported protocol adherence in the aphasia litera-
ture, in excess of 90% therapist adherence (Behn et al., 2018; Conlon et al., 2020). 
A current therapy fidelity protocol for the Action Success Knowledge (ASK) trial has set 
integrity at 100% adherence to essential therapeutic criteria in a session and 80% 
overall adherence to protocol to deem therapists as meeting criteria (Carragher et al., 
2019). It is important to note that instances where sessions deviated from the target 
goal level may have been a reflection of clinical intuition and responsiveness to the 
participant and inadvertently caused infidelity to the treatment protocol.
Treatment differentiation
At the broader task level, the VERSE treatment arm contained more verbal output, less 
single-word tasks, and more conversation-based tasks than the Usual Care-Plus treatment 
arm as per protocol. However, when the therapeutic inputs and client acts were examined 
at the utterance level, the treatments did not differ significantly. As expected, the tasks 
completed in the prescribed VERSE therapy were different from the treatment provided in 
Usual Care-Plus, however the therapist input, related to the amount of cueing provided to 
support participant success as well as the amount of language produced by the therapist, 
was similar for therapists in both arms of the trial. It may be that even if different therapy 
tasks were used, the manner in which clinicians supported the participants within the 
treatment sessions was similar. This may reflect clinicians’ perspectives around best 
practice for supporting patients in treatment sessions or their understanding of facilitat-
ing neural recovery through limiting errors and providing individual opportunities to 
produce verbal output. A related explanation concerns the underlying theoretical 
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mechanism underpinning language therapy. As hypothesized previously, the underlying 
therapeutic mechanism at work in language therapy may be irrespective of task or 
therapeutic inputs (Godecke et al., 2016).
In exploring treatment fidelity, it is important to consider the way in which the therapy 
is delivered as well as the role of the person who receives the therapy, the person with 
aphasia in this case (Bellg et al., 2004). People with aphasia are a heterogeneous popula-
tion (Brady et al., 2016), with considerable variation in relation to how aphasia may 
present. Even within the same aphasia classification, such as Broca’s or Wernicke’s 
aphasia, the number of errors made or the types of cues that are helpful may be very 
different from one person to the next. However, homogeneity can be observed within 
PWA during therapy. The tasks used between therapy groups and between therapists 
were different; however, the interaction frequently elicited the same behaviour from 
people with aphasia. It is possible that people with aphasia were reasonably predictable 
once their individual error pattern and response to cues was established. Therefore, 
regardless of the assigned therapy group, the presence or absence of a protocol, the 
therapist’s attempts to manipulate a session, minimise or maximise errors, PWA 
responded in a particular pattern. And so, another possible explanation for the lack of 
treatment differentiation at the utterance level in client acts is that regardless of the 
therapy provided, the response of PWA was similar across the intervention groups. This 
may relate to the reinforcement of error patterns by PWA regardless of the approach 
taken by the therapist (Conroy et al., 2009).
Interpretation of main trial results
Therapy fidelity data is vital to support the interpretation of the main trial outcomes, 
especially in behavioural research (Walton et al., 2017). The main VERSE trial results found 
that there was not a main effect for treatment intensity (Godecke et al., 2020b). Clinicians 
within in the VERSE and Usual Care-Plus arms of the trial were required to record 20% of their 
treatment sessions, in line with recommendations for long-term monitoring (Borrelli, 2011). 
This study provided a detailed examination of 12% of the videos received through the trial. 
As this is only a small percentage of the total number of therapy sessions completed, we 
cannot say with certainty whether this sample is representative of all therapy given, how-
ever, we feel the analyses completed and results found provide important insight into the 
therapy provided within this trial. If the results from this study are extrapolated to the 
broader VERSE RCT the findings suggest that therapists were adherent to the therapy 
protocol for the prescribed VERSE arm of the trial and that while the therapies, provided 
in the VERSE and Usual Care-Plus arms of the trial, contained different tasks and target 
language levels, how the therapists interacted with participants was not different. 
Specifically, the number of cues used by therapists to support participants, the success of 
these cues, the amount of verbal output from the therapist, and the PWA, were not 
significantly different. We are cautious with extrapolating this result to the entire VERSE 
RCT sample, however it could provide one potential explanation for why the prescribed 
VERSE therapy arm and Usual Care-Plus did not perform differently in statistical analyses for 
the primary outcome measures. It is likely that both conditions share the key elements of 
aphasia therapy, that is therapists within the Usual Care-Plus condition provided treatment 
elements at the micro level that share the key elements of the VERSE intervention. This may 
APHASIOLOGY 17
relate to the VERSE intervention being a good reflection of existing practice, therefore 
promoting adherence. Additionally, therapists delivering Usual Care-Plus may already have 
been employing the key neuroplasticity principles that the VERSE prescribed intervention 
contained. It is unlikely that this is due to contamination between conditions as the VERSE 
intervention was shown to be statistically different at the task level of intervention 
prescription.
Recommendations for future trials
We would encourage researchers to undertake fine-grained analyses of treatments 
provided within complex, behavioural interventions in the early (pilot) phases of 
intervention studies. These fine-grained analyses may reveal important underlying 
factors in the way the intervention is provided or received by participants that require 
further investigation and understanding in order to interpret trial results. Examining 
differentiation in the treatments provided may not be sufficient if participant behaviour 
or acts have the potential to impact clinician behaviour as the therapy session pro-
gresses. It will be important to consider this relationship further in complex behavioural 
trials.
This study established that reviewing aphasia therapy videos from an RCT and coding 
these for key measures is feasible, however data analyses were lengthy due to the in- 
depth nature of the analyses completed. Further research is needed to develop 
a greater understanding of the behaviours that should be investigated in establishing 
treatment integrity and differentiation and the most efficient ways of evaluating these 
components. As this study was the first undertaken of this nature, a scoping process was 
used. If a pilot study is used and the researcher is confident that key intervention 
ingredients have been identified resulting in a more targeted approach, the practic-
ability may be increased.
Limitations
This study is the first of its kind to provide a detailed analysis of therapy sessions within an 
aphasia-based RCT. However, it is acknowledged that a small number (12%) of the 
available trial videos were analysed and so there is a limit to the extrapolation of results 
to across the trial as a whole. It is also possible that the study was underpowered to find 
differences between the groups. The primary rater for the videos was not blinded to the 
treatment condition; however, unblinding was necessary for monitoring protocol adher-
ence, and treatments were also easily distinguishable based on task selection. We do 
acknowledge the potential for bias.
Conclusion
Aphasia RCTs are encouraged to routinely report therapy fidelity data to assist research 
consumers with their interpretation of trial results. We report high treatment integrity 
within the VERSE trial. Determining the active ingredients and dosage level to ensure 
treatment differentiation is an ongoing goal for aphasia trials. Micro-level analysis of 
therapy sessions may reveal important underlying factors for further investigation and 
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only when the treatments are determined to be sufficiently different and the target 
dosage is achieved, can the efficacy question be answered.
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